MALIGNANT URETHRAL NEOPLASM

Clinical trials for MALIGNANT URETHRAL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT URETHRAL NEOPLASM trials appear

Sign up with your email to follow new studies for MALIGNANT URETHRAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a targeted antibody-drug combo tackle rare bladder cancers?

Disease control Recruiting now

This phase II trial is testing whether combining enfortumab vedotin—a drug that delivers a cancer-killing agent directly to tumor cells—with the immunotherapy pembrolizumab can shrink tumors in people with locally advanced or metastatic bladder cancer of variant histology. These …

Matched conditions: MALIGNANT URETHRAL NEOPLASM

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

MALIGNANT URETHRAL NEOPLASM

Get alerted when new MALIGNANT URETHRAL NEOPLASM trials appear

Can a targeted antibody-drug combo tackle rare bladder cancers?